308 related articles for article (PubMed ID: 35042519)
41. SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.
Cui XB; Shen YY; Jin TT; Li S; Li TT; Zhang SM; Peng H; Liu CX; Li SG; Yang L; Li N; Hu JM; Jiang JF; Li M; Liang WH; Li Y; Wei YT; Sun ZZ; Wu CY; Chen YZ; Li F
J Transl Med; 2015 Oct; 13():321. PubMed ID: 26444413
[TBL] [Abstract][Full Text] [Related]
42. A 10‑microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
Sun Q; Zong L; Zhang H; Deng Y; Zhang C; Zhang L
Mol Med Rep; 2018 Apr; 17(4):5222-5228. PubMed ID: 29393486
[TBL] [Abstract][Full Text] [Related]
43. Serum tRNA-derived small RNAs as potential novel diagnostic biomarkers for pancreatic ductal adenocarcinoma.
Xue M; Shi M; Xie J; Zhang J; Jiang L; Deng X; Peng C; Shen B; Xu H; Chen H
Am J Cancer Res; 2021; 11(3):837-848. PubMed ID: 33791157
[TBL] [Abstract][Full Text] [Related]
44. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma.
Li W; Zhang L; Guo B; Deng J; Wu S; Li F; Wang Y; Lu J; Zhou Y
Mol Cancer; 2019 Feb; 18(1):22. PubMed ID: 30736860
[TBL] [Abstract][Full Text] [Related]
45. Exosomal lncRNA FAM225A accelerates esophageal squamous cell carcinoma progression and angiogenesis via sponging miR-206 to upregulate NETO2 and FOXP1 expression.
Zhang C; Luo Y; Cao J; Wang X; Miao Z; Shao G
Cancer Med; 2020 Nov; 9(22):8600-8611. PubMed ID: 33006432
[TBL] [Abstract][Full Text] [Related]
46. Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy.
Wang XB; Jiang XR; Yu XY; Wang L; He S; Feng FY; Guo LP; Jiang W; Lu SH
Cancer Sci; 2014 Feb; 105(2):176-85. PubMed ID: 24383865
[TBL] [Abstract][Full Text] [Related]
47. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
[TBL] [Abstract][Full Text] [Related]
48. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.
Takeshita N; Hoshino I; Mori M; Akutsu Y; Hanari N; Yoneyama Y; Ikeda N; Isozaki Y; Maruyama T; Akanuma N; Komatsu A; Jitsukawa M; Matsubara H
Br J Cancer; 2013 Feb; 108(3):644-52. PubMed ID: 23361059
[TBL] [Abstract][Full Text] [Related]
49. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J
Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915
[TBL] [Abstract][Full Text] [Related]
50. Predictive value of the presence of
Chen X; Xian B; Wei J; Chen Y; Yang D; Lai X; Liu L; Wu Y; Lin X; Deng Y; Zhang H; Liu W; Qiao G; Li Z
Front Cell Infect Microbiol; 2022; 12():997333. PubMed ID: 36310858
[TBL] [Abstract][Full Text] [Related]
51. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.
Tanaka Y; Kamohara H; Kinoshita K; Kurashige J; Ishimoto T; Iwatsuki M; Watanabe M; Baba H
Cancer; 2013 Mar; 119(6):1159-67. PubMed ID: 23224754
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
53. Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma.
Zhang C; Guo Z; Jing Z
Int J Nanomedicine; 2024; 19():1351-1362. PubMed ID: 38352821
[TBL] [Abstract][Full Text] [Related]
54. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.
Jin Y; Meng Q; Zhang B; Xie C; Chen X; Tian B; Wang J; Shih TC; Zhang Y; Cao J; Yang Y; Chen S; Guan X; Chen X; Hong A
Int J Biol Sci; 2021; 17(14):3689-3701. PubMed ID: 34671193
[TBL] [Abstract][Full Text] [Related]
55. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
Tong YS; Zhou XL; Wang XW; Wu QQ; Yang TX; Lv J; Yang JS; Zhu B; Cao XF
J Transl Med; 2014 Aug; 12():233. PubMed ID: 25169763
[TBL] [Abstract][Full Text] [Related]
56. Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells.
Yang L; Zheng S; Liu Q; Liu T; Zhang Q; Han X; Tuerxun A; Lu X
Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34396437
[TBL] [Abstract][Full Text] [Related]
57. Prognostic and immunological role of cancer-associated fibroblasts-derived exosomal protein in esophageal squamous cell carcinoma.
Wang Z; Zhang M; Liu L; Yang Y; Qiu J; Yu Y; Li J
Int Immunopharmacol; 2023 Nov; 124(Pt A):110837. PubMed ID: 37634448
[TBL] [Abstract][Full Text] [Related]
58. USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Peng J; Hu Q; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Wei W; Liu S; Wang H
Diagn Pathol; 2013 Oct; 8():177. PubMed ID: 24152793
[TBL] [Abstract][Full Text] [Related]
59. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma.
Yan S; Du L; Jiang X; Duan W; Li J; Xie Y; Zhan Y; Zhang S; Wang L; Li S; Wang C
Cancer Manag Res; 2020; 12():9753-9763. PubMed ID: 33116835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
